Zinplava bezlotoxumab regulatory update

FDA approved a BLA for Zinplava bezlotoxumab from Merck to reduce recurrence of Clostridium difficile infection (CDI) in adults receiving antibacterial drug treatment of CDI and are at high risk for r...